Ukuthuthukisa amandla akho
I-NADH, noma ukunciphisa i-nicotinamide adenine dinucleotide, yenziwa emzimbeni wakho kusuka ku-niacin, i-vitamin B. Kuqukethwe kuwo wonke amaseli aphilayo.
I-NADH isisongezelo esivamile kubantu abano-fibromyalgia (i-FMS) nesifo esingapheliyo sokukhathala ( ME / CFS ). Ukusetshenziswa kwalo, ikakhulukazi ku-FMS, kusekelwe kakhulu ebufakazini bokuqala kanye nokulinganisa okulinganayo phakathi kwemisebenzi eyaziwayo yenkampani kanye nemibandela 'yokuntuleka nokuziwayo.
Nasi isizathu:
- Njengoba i-coenzyme, i-NADH isisiza ama-enzyme emzimbeni wakho aphule ukudla futhi aguqulwe ibe namandla ngendlela ye- adenosine triphosphate (ATP) . Izifundo zibonisa ukuthi abanye abantu abanezimo bangase babe namazinga aphansi we-ATP.
- Ucwaningo lubonisa ukuthi i-NADH ingashukumisa ukusebenza kobuchopho, okungasiza ekunciphiseni ukukhubazeka kwengqondo okuhambisana neFMS ne-ME / CFS.
- I-NADH inganciphisa ukukhathala kwezifo ezingapheli ngokubuyisela umsebenzi we-mitochondria (izakhiwo ezincane ezenza amangqamuzana akho asebenze.) Ukukhathala kuyisimo esiyinhloko kokubili i-FMS ne-ME / CFS futhi kokubili izimo zikholelwa ukuthi zibandakanya ukungasebenzi komzimba .
- I-NADH ikholelwa ukuthi i-antioxidant, engasiza nge-stress oxidative ne-nitrosative ehambisana nalezi zimo.
- I-NADH ingasiza ubuchopho bakho ukuthi budale ama-neurotransmitters (izithunywa zamakhemikhali) ezikholelwa ukuthi zihlulekile kulezi zimo (i- serotonin , i- norepinephrine , i- dopamine ne- GABA .)
Asinaso ucwaningo ku-NADA ye-FMS. Ukucwaninga okulinganiselwe kubonisa ukuthi i-NADH ingaba ukwelashwa okuphumelelayo kwe-ME / CFS kanye nokucindezeleka , isifo sika-Parkinson nesifo se-Alzheimer . Kodwa-ke, ukutadisha okwengeziwe kuyadingeka ngaphambi kokuthi sitshele ukuthi ukwelashwa okungcono kangakanani kunoma iziphi izifo.
I-NADH ye-Chronic Fatigue Syndrome
Ucwaningo oluthile lubukeze ukwesekwa nge-NADH plus coenzyme Q10 kubantu abane ME / CFS.
Enye eyanyatheliswa ngo-2015 iphakamise ukunciphisa okukhulu kokukhathala okuhambisana ne-placebo.
Esinye, eshicilelwe ngo-2016, siboniswe ukubonisa isilinganiso esiphezulu senhliziyo ngesikhathi sokuvivinya umzimba. Lokhu kungasho ukuthi kuzosiza nge -malaise emva kokucindezela , okuyisifo esichazayo saleso sifo.
Ukubuyekezwa kuka-2011 kwezincwadi ezitholakalayo ezibizwa ngokuthi i-NADH ne- magnesium njengezithako ezimbili kuphela eziboniswe ukuthuthukisa i-ME / CFS kwizifundo.
Ucwaningo lwangaphambili lwaluphakamisa ukuthuthukiswa kokukhathazeka nesilinganiso senhliziyo esiphezulu ngemva kokuhlolwa kokucindezeleka.
Isilinganiso se-NADH
Izithako ze-NADH zitholakala kakhulu futhi azidingi udokotela.
Isilinganiso esiphephile, esisebenzayo se-FMS ne-ME / CFS asisungulwa. Ngokuvamile, isilinganiso esinconywayo ngokuvamile si-5 mg kuya ku-10 mg ngosuku. Kumele kuthathwe amaminithi angu-30 ngaphambi kokudla ngesisu esingenalutho.
Ezifundweni zesifo sikaPasinson, umthamo osebenza kahle kakhulu uhlonzwe njengo-25 mg kuya ku-50 mg ngosuku.
I-NADH ekudleni kwakho
Kulula ukuthola i-NADH eyengeziwe ngokudla kwakho. Asazi, noma ngabe umzimba wakho usebenzisa i-NADH yokudla ngendlela efanele njengoba ifomu lokugcwalisa.
Imithombo ye-NADH yokudla ihlanganisa:
- Inhlanzi
- Izinkukhu
- Inkomo
- Imikhiqizo equkethe imvubelo
Imiphumela emibi ye-NADH
Imiphumela emibi ye-NADH ayivamile, ikakhulu emazingeni aphansi.
Amanani aphakeme ahlobene nalokhu:
- Izwa sengathi igxilile
- Ukungalali
- Ukukhathazeka
Ngenkathi ukugcwaliswa kwe-NADH kubonakala kuphephile, kufanele usalinde imiphumela emibi.
Izwi elivela
Uma ucabanga ukuthi ungase uzuze ezisekelweni ze-NADH, qiniseka ukuthi ukhuluma nodokotela wakho ngakho. Kungumqondo omuhle wokukukhuphula kanye nomuthi wakho wezemithi, owazi ukuthi izindlela ezahlukene zokwelashwa zingase zisebenzisane kanjani emzimbeni wakho.
> Imithombo:
> Alegre J, Roses JM, uJavierre C, et al. I-Nictinamide Adenine Dinucleotide (i-NADH) ezigulini ezine-Chronic Patience Syndrome. Revista Clinica Espanola. 2010 Jun; 210 (6): 284-8. doi: 10.1016 / j.rce.2009.09.015. Isihloko ngesi-Spanish; Okubhaliwe okukhonjisiwe.
> Alraek T, Lee MS, Choi TY, et al. Imithi Ephelele Neyengane Eyabantu Abagulayo Abanesifo Sokuphela Kwokukhathala: Isibuyekezo Esihlelekile. I-BMC Complementary and Alternative Medicine. 2011 Okthoba 7; 11: 87. i-doi: 10.1186 / 1472-6882-11-87.
> I-Castro-Marrero J, i-Cordero MD, iSegundo MJ, et al. Ingabe i-Oral Coenzyme Q10 Plus I-NADH Supplementation ithuthukise ukukhathala kanye ne-Biochemical Parameters ku-Chronic Fatigue Syndrome? 2015 Mar 10; 22 (8): 679-85. i-doi: 10.1089 / i-ars.2014.6181.
> Castro-Marrero J, uSaez-Francas N, Segundo MJ, et al. Imiphumela yeCoenzyme Q10 Plus iNicotinamide Adenine Dinucleotide Supplementation nge-Maximu Heart Rate Ngemuva kokuhlolwa kokuzivocavoca ekukhatheni okungapheli Syndrome - Isivivinyo Esingahleliwe, Esilawulwayo, Esiyizimpumputhe. Ukudla okunomtholampilo (e-Edinburgh, eScotland). 2016 Aug; 35 (4): 826-34. i-doi: 10.1016 / j.clnu.2015.07.010.
> Nicolson GL. Ukukhubazeka Kwemitochondrial kanye Nezifo Eziphuthumayo: Ukwelashwa Ngezidingo Zemvelo. Ezinye izindlela zokwelapha ezempilo nemithi. Ubusika buka-2014; 20 Isamba 1: 18-25.